PharmaBoardroom

In the pharma world, managers change frequently from one company to another, and this phenomenon has been accelerated with the consolidation of the…

Since this interview, Michael Ryde has left Lundbeck China and is now working as Commercial Counsellor, Teamleader Health, at the Danish Embassy in…

Polski Holding Farmaceutyczny (PHF) was put together in 2004 as a capital group consisting of three leading Polish pharma producers and the mission…

For years Polpharma has been the market leader in Poland. In many countries the arrival of multinational companies (MNCs) led to the loss of…

Mr. Medda, Teva’s Italian history is relatively young, could you describe the main facts that describe Teva presence in Italy? Teva Italia was…

Unlike many pharmaceutical companies, Servier fully operates in all pharma business activities in Poland: research, drug manufacturing and…

With the current acquisition of Genzyme by Sanofi-Aventis, the French giant is planning to have Genzyme as a centre of excellence for rare diseases.…

Would you begin by explaining to the readers of Pharmaceutical Executive the importance of the operation in Poland for the company? Indeed Poland…

In order to provide our readers with a general idea of the current state of the Romanian pharmaceutical and healthcare sectors, can you first of all…

As we are just starting 2011, could you share with us the results of Nycomed Poland in 2010? In 2010, the affiliate has not been as successful as…

Firstly, what attracted you to join the CRO industry with Quintiles over 10 years ago? I had been working for 5 years as a doctor in the internal…

Servier was one of the first pharmaceutical companies to establish a presence in China back in 1979. How has Servier’s presence evolved…